AEON Biopharma Statistics
Total Valuation
AEON Biopharma has a market cap or net worth of $8.61 million. The enterprise value is $16.44 million.
Important Dates
The last earnings date was Tuesday, August 12, 2025, after market close.
Earnings Date | Aug 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
AEON Biopharma has 11.64 million shares outstanding. The number of shares has decreased by -94.62% in one year.
Current Share Class | 11.64M |
Shares Outstanding | 11.64M |
Shares Change (YoY) | -94.62% |
Shares Change (QoQ) | +177.80% |
Owned by Insiders (%) | 29.18% |
Owned by Institutions (%) | 16.73% |
Float | 8.20M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.12
Current Ratio | 1.12 |
Quick Ratio | 0.92 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -129.01% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | -708.80% |
Revenue Per Employee | n/a |
Profits Per Employee | -$327,200 |
Employee Count | 5 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.66% in the last 52 weeks. The beta is 0.71, so AEON Biopharma's price volatility has been lower than the market average.
Beta (5Y) | 0.71 |
52-Week Price Change | -98.66% |
50-Day Moving Average | 0.77 |
200-Day Moving Average | 8.92 |
Relative Strength Index (RSI) | 48.56 |
Average Volume (20 Days) | 81,383 |
Short Selling Information
The latest short interest is 253,955, so 2.18% of the outstanding shares have been sold short.
Short Interest | 253,955 |
Short Previous Month | 361,308 |
Short % of Shares Out | 2.18% |
Short % of Float | 3.10% |
Short Ratio (days to cover) | 2.26 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -17.95M |
Pretax Income | n/a |
Net Income | -1.64M |
EBITDA | -17.87M |
EBIT | -17.95M |
Earnings Per Share (EPS) | -$0.40 |
Full Income Statement Balance Sheet
The company has $8.44 million in cash and $16.44 million in debt, giving a net cash position of -$8.00 million or -$0.69 per share.
Cash & Cash Equivalents | 8.44M |
Total Debt | 16.44M |
Net Cash | -8.00M |
Net Cash Per Share | -$0.69 |
Equity (Book Value) | -15.85M |
Book Value Per Share | -1.37 |
Working Capital | 1.13M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$13.58 million and capital expenditures -$4,000, giving a free cash flow of -$13.58 million.
Operating Cash Flow | -13.58M |
Capital Expenditures | -4,000 |
Free Cash Flow | -13.58M |
FCF Per Share | -$1.17 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
AEON Biopharma does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 94.62% |
Shareholder Yield | 94.62% |
Earnings Yield | -19.38% |
FCF Yield | -160.87% |
Analyst Forecast
The average price target for AEON Biopharma is $360.00, which is 48,588.13% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $360.00 |
Price Target Difference | 48,588.13% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on February 26, 2025. It was a reverse split with a ratio of 1:72.
Last Split Date | Feb 26, 2025 |
Split Type | Reverse |
Split Ratio | 1:72 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |